(Health-NewsWire.Net, August 26, 2016 ) Technavio Announces the Publication of its Research Report Global Over-The-Counter (OTC) Drug Market 2016-2020Technavio recognizes the following companies as the key players in the global over-the-counter (OTC) drug market: GSK, Johnson & Johnson, Pfizer, Bayer...
(Health-NewsWire.Net, August 26, 2016 ) Drug discovery platform is a place of research and development where medicines are identified for various diseases. Currently, the drug discovery platform is witnessing massive adoption of digital technologies. Cloud-based drug discovery platforms are gaining...
(Health-NewsWire.Net, August 26, 2016 ) The report also focuses on the development trends as well as history, competitive landscape analysis, and key regions etc in the international markets.Global Picture Archiving and Communication Systems (PACS) Sales Industry 2021 Market Research Report is a...
Research N Reports(Health-NewsWire.Net, August 26, 2016 ) This report on the global Medical Column Industry is an amalgamation of both primary as well as secondary research and is collated by conducting various surveys and interviews. It is a meticulous guide that covers the global Medical Column...
Research N Reports(Health-NewsWire.Net, August 26, 2016 ) This report on the global Medical Incinerator Industry is an amalgamation of both primary as well as secondary research and is collated by conducting various surveys and interviews. It is a meticulous guide that covers the global Medical...
(Health-NewsWire.Net, August 26, 2016 ) With the ageing population and the increased incidence of cardiovascular diseases, current gold standard anticoagulants have become unable to satisfy the treatment demand. It is inevitable for improved drugs to come into the market. Warfarin and heparin which...
(Health-NewsWire.Net, August 26, 2016 ) FSH brought in a global sales value of over USD 1.2 billion in 2013 to which Gonal-f (FSH?) made by Merck Serono contributed USD 813 million with a market share of 63% while Puregon (FSH?) of Merck contributed USD 481 million with a market share of 37%. FSH...
(Health-NewsWire.Net, August 26, 2016 ) Through years of development, ambroxol, the third generation of expectorant, has been widely applied in the clinic. The chemical composition of ambroxol is ambroxol hydrochloride which is the active metabolite of bromhexine. First developed and registered...
(Health-NewsWire.Net, August 26, 2016 ) Parecoxib is a kind of COX-2 inhibitor which compared with opioid, can effectively inhibit COX-2 expression and reduce the synthesis of prostaglandin in the central and peripheral nervous system, inhibit hyperalgesia and increase pain threshold. Parecoxibs...
(Health-NewsWire.Net, August 26, 2016 ) Since its first marketing in France in 1992, piperacillin sodium and tazobactam sodium has entered the US, mainland Europe, Japan and Singapore. According to CRIs market survey, piperacillin sodium and tazobactam sodium develops fast after entering China...
(Health-NewsWire.Net, August 26, 2016 ) The report "In-mold labels Market In-mold labels Market by Technology (Injection Molding, Extrusion, Thermoforming), Material (PP, PE, ABS, PVC, Others), Printing Technology (Flexographic, Offset, Gravure), Printing inks, End Use (Food & Beverage, Consumer...
(Health-NewsWire.Net, August 26, 2016 ) It is estimated that the number of osteoporosis patients and patients with low bone mass will rise to 280 million by 2020.Currently, drugs for the prevention and treatment of osteoporosis are mainly categorized into bone resorption inhibitor which includes...
(Health-NewsWire.Net, August 26, 2016 ) With the sustained economic development and the improvements in diet, Chinese peoples blood fat level rises too. Many local epidemiological studies on blood fat have proved that a conservative estimate of the incidence of hyperlipemia is 7%-8% while...
(Health-NewsWire.Net, August 26, 2016 ) Quinolones, an up-rising antimicrobial, has increasingly attained attention around the world. As a levo isomer of ofloxacin, levofloxacin has the same spectrum as ofloxacin with stronger antibacterial activity and lower toxicity. First developed and marketed...
(Health-NewsWire.Net, August 26, 2016 ) Raloxifene (raloxifene hydrochloride), a non-hormone drug against bone resorption, belongs to the second generation of selective estrogen receptor modulator (SERMs). Different from traditional estrogen replacement therapy (ERT) or hormone replacement therapy...
|